CN Patent

CN112585130A — 蛋白酶体活性增强化合物

Assigned to Protein Balance Therapy Co ltd · Expires 2021-03-30 · 5y expired

What this patent protects

本发明涉及抑制Usp14的化合物、其组合物以及用于治疗与蛋白稳态失调有关的病症的方法。

USPTO Abstract

本发明涉及抑制Usp14的化合物、其组合物以及用于治疗与蛋白稳态失调有关的病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112585130A
Jurisdiction
CN
Classification
—
Expires
2021-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Protein Balance Therapy Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.